Page last updated: 2024-08-21
dronabinol and ji-38
dronabinol has been researched along with ji-38 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Aguado, T; Alberch, J; Benito, C; Blázquez, C; Börner, C; Carrasco, C; Chiarlone, A; de Yébenes, JG; Díaz-Hernández, M; Diez-Zaera, M; Fernández-Ruiz, J; Galve-Roperh, I; Ginés, S; Guzmán, M; Julien, B; Kraus, J; Lucas, JJ; Lutz, B; Marsicano, G; Monory, K; Palazuelos, J; Paoletti, P; Pazos, MR; Resel, E; Romero, J; Ruiz, C; Sagredo, O; Salazar, M; Sendtner, M | 1 |
Other Studies
1 other study(ies) available for dronabinol and ji-38
| Article | Year |
|---|---|
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Survival; Corpus Striatum; Dronabinol; Growth Hormone-Releasing Hormone; Huntington Disease; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Motor Activity; Neurons; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; Rotarod Performance Test | 2011 |